Aegis Sciences and Walgreens expand COVID-19 diagnostic testing

Aegis Sciences Corp. and Walgreens plan to provide additional COVID-19 testing capacity across more than 3,000 Walgreens pharmacy locations in February. The move will allow Walgreens to significantly increase its COVID-19 testing capacity, and further growth is expected in the coming months. Early last fall, Aegis was selected to participate in the NIH Rapid Acceleration of Diagnostics (RADx) initiative and received a grant to expand COVID-19 testing capacity to 60,000 tests per day by September 30. Since then, Aegis has further increased capacity and is currently able to perform over 100,000 tests per day within a targeted 24-hour or less turnaround time. Aegis received an additional NIH grant in January 2021 due to the success in quickly expanding its testing program. Since launching COVID-19 testing in April 2020, Aegis has performed more than 3 million COVID-19 tests.